Therapeutic response to rituximab in seropositive neuromyelitis optica: Experience from a tertiary care center in South India.

J Neurosci Rural Pract · 2023 · PMC10174152 · PMID 37181182

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

100%), it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.